Katherine Elizabeth Francis

3PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 05, 2025
Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial.

Chee Khoon Lee, Apriliana E R Kartikasari, Nirashaa T Bound

|Jul 24, 2025
Under the radar-frequency, timing, duration, and trajectory of lower-grade adverse events in clinical trials of anti-cancer therapies.

Katherine E Francis, Sarah J Lord, Sandy Simon

|Dec 14, 2023
Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer.

Danka Sinikovic Zebic, Angelina Tjokrowidjaja, Katherine Elizabeth Francis

Pageof 1

Frequent Collaborators

2 joint publications

Michael Friedlander

1 joint publications

Chee Khoon Lee

1 joint publications

Nirashaa T Bound

1 joint publications

Kristy Shield-Artin